Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mareike Lankeit

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Journal of Thrombosis and Thrombolysis|September 1, 2016
Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort studyStavros V Konstantinides, Stefano Barco, Stephan Rosenkranz, et al.
Thrombosis and Haemostasis|September 24, 2021
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trialOlivier Sanchez, Anaïs Charles-Nelson, Walter Ageno, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 20, 2018
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trialStefano Barco, Mariaconcetta Russo, Eric Vicaut, et al.
Chest|February 6, 2021
Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism: Analysis From a Prospective Multicenter Cohort StudyLuca Valerio, Stefano Barco, Marius Jankowski, et al.
Thrombosis and Haemostasis|December 7, 2017
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 StudyFrederikus A Klok, Walter Ageno, Stefano Barco, et al.
European Heart Journal|April 29, 2022
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS studyLuca Valerio, Anna C Mavromanoli, Stefano Barco, et al.
The Lancet. Haematology|August 7, 2021
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trialFrederikus A Klok, Gerrit Toenges, Anna C Mavromanoli, et al.
The New England Journal of Medicine|April 11, 2014
Fibrinolysis for patients with intermediate-risk pulmonary embolismGuy Meyer, Eric Vicaut, Thierry Danays, et al.
European Heart Journal|May 24, 2019
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trialStefano Barco, Irene Schmidtmann, Walter Ageno, et al.
The European Respiratory Journal|August 30, 2020
Survival and quality of life after early discharge in low-risk pulmonary embolismStefano Barco, Irene Schmidtmann, Walter Ageno, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Journal of Thrombosis and Thrombolysis|September 1, 2016
Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort studyStavros V Konstantinides, Stefano Barco, Stephan Rosenkranz, et al.
Thrombosis and Haemostasis|September 24, 2021
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trialOlivier Sanchez, Anaïs Charles-Nelson, Walter Ageno, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|December 20, 2018
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trialStefano Barco, Mariaconcetta Russo, Eric Vicaut, et al.
Chest|February 6, 2021
Quality of Life 3 and 12 Months Following Acute Pulmonary Embolism: Analysis From a Prospective Multicenter Cohort StudyLuca Valerio, Stefano Barco, Marius Jankowski, et al.
Thrombosis and Haemostasis|December 7, 2017
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 StudyFrederikus A Klok, Walter Ageno, Stefano Barco, et al.
European Heart Journal|April 29, 2022
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS studyLuca Valerio, Anna C Mavromanoli, Stefano Barco, et al.
The Lancet. Haematology|August 7, 2021
Early switch to oral anticoagulation in patients with acute intermediate-risk pulmonary embolism (PEITHO-2): a multinational, multicentre, single-arm, phase 4 trialFrederikus A Klok, Gerrit Toenges, Anna C Mavromanoli, et al.
The New England Journal of Medicine|April 11, 2014
Fibrinolysis for patients with intermediate-risk pulmonary embolismGuy Meyer, Eric Vicaut, Thierry Danays, et al.
European Heart Journal|May 24, 2019
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trialStefano Barco, Irene Schmidtmann, Walter Ageno, et al.
The European Respiratory Journal|August 30, 2020
Survival and quality of life after early discharge in low-risk pulmonary embolismStefano Barco, Irene Schmidtmann, Walter Ageno, et al.
Pageof 11